BioSpace News Archive

FDA

Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)

Arena Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to etrasimod.

June 9, 2021
·
5 min read
Drug Development

Results from Qu Biologics’ Crohn’s Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021

Qu Biologics Inc. is pleased to announce that the data from QBECO-CD-02, Qu’s Phase 2 study of QBECO SSI treatment for Crohn’s disease, was selected for an oral presentation at the 16th Congress of European Crohn’s and Colitis Organization, a leading GI conference.

June 9, 2021
·
4 min read
Genetown

Vericel to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021

Vericel Corporation today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Goldman Sachs 42 nd Annual Global Healthcare Conference.

June 9, 2021
·
1 min read
Biotech Bay

DURECT Corporation to Present Additional Clinical Data from DUR-928 Studies in NASH (Phase 1b) and in Hepatic Impairment (Phase 1) at Upcoming International Liver Conference 2021 (EASL)

DURECT Corporation (Nasdaq: DRRX) today announced it will present two posters at the 2021 International Liver Conference (EASL) to be held virtually June 23-26 , 2021.

June 9, 2021
·
4 min read
Lone Star Bio

Texas Children’s Hospital Center for Vaccine Development COVID-19 Subunit Vaccine Candidate Advancing Towards Global Access

Texas Children’s Hospital and Baylor College of Medicine leading COVID-19 subunit vaccine candidate, developed with Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company, has received approval to proceed with Phase III clinical trials in India.

June 9, 2021
·
3 min read
Business

Celcuity Announces Appointment of Dr. Igor Gorbatchevsky as VP of Clinical Development and Jill Krause as VP of Clinical Operations

Celcuity Inc. today announced the addition of two new senior executives. Igor Gorbatchevsky, MD, joined Celcuity as VP of Clinical Development and Jill Krause joined as VP of Clinical Operations.

June 9, 2021
·
5 min read
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Androgenic Alopecia

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), announced that the companies signed an exclusive contract to scale production of OliX’s OLX104C, an investigational RNAi therapeutic in development for the treatment of androgenic alopecia.

June 9, 2021
·
3 min read
New next generation device improves the well-being of people affected by swallowing disorders and dysphagia

The Mobili-T® system was brought to market by a health company, True Angle, an award-winning startup that just raised an oversubscribed $1.64M investment round backed by investment firms such as Accelerate Fund, Thin Air Labs, The 51 and others.

June 9, 2021
·
2 min read
Drug Development

PainQx Awarded $1.5M Phase II SBIR Contract from the Defense Health Agency SBIR Program to Refine Objective Pain Assessment Technology

PainQx, Inc. (www.painqx.com), is pleased to announce it has been awarded a Defense Health Agency (www.health.mil) Phase II SBIR contract.

June 9, 2021
·
2 min read
Smart Syringes Market Technological Developments in The Field of Smart Syringes

The market is estimated to grow with a CAGR of 10.6% from 2019-2027.

June 9, 2021
·
5 min read